Usually, in tumor cells with BRCA1 and BRCA2 mutations or defects, the inhibition of the PARP enzyme can lead to the accumulation of single-strand DNA breaks, owing to the HR repair pathway being blocked, which causes further double-strand DNA breaks and finally results in the death of tumor cells [6,7,8]. Here, PARP1 is linked to neoplasm.